98 related articles for article (PubMed ID: 9234263)
1. Preparation and pharmacological characterization of [76Br]-meta-bromobenzylguanidine ([76Br]MBBG).
Loc'h C; Mardon K; Valette H; Brutesco C; Merlet P; Syrota A; Maziere B
Nucl Med Biol; 1994 Jan; 21(1):49-55. PubMed ID: 9234263
[TBL] [Abstract][Full Text] [Related]
2. Bromine-76-metabromobenzylguanidine: a PET radiotracer for mapping sympathetic nerves of the heart.
Valette H; Loc'h C; Mardon K; Bendriem B; Merlet P; Fuseau C; Sabry S; Raffel D; Mazière B; Syrota A
J Nucl Med; 1993 Oct; 34(10):1739-44. PubMed ID: 8410291
[TBL] [Abstract][Full Text] [Related]
3. PET imaging of norepinephrine transporter-expressing tumors using 76Br-meta-bromobenzylguanidine.
Watanabe S; Hanaoka H; Liang JX; Iida Y; Endo K; Ishioka NS
J Nucl Med; 2010 Sep; 51(9):1472-9. PubMed ID: 20720048
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of the norepinephrine analog [76Br]-meta-bromobenzylguanidine in isolated working rat heart.
Raffel D; Loc'h C; Mardon K; Mazière B; Syrota A
Nucl Med Biol; 1998 Jan; 25(1):1-16. PubMed ID: 9466356
[TBL] [Abstract][Full Text] [Related]
5. 76Br-MBBG, a PET radiotracer to investigate the norepinephrine neurological and vesicular transproters in the heart.
Maziere B; Valette H; Loc'h C
Nucl Med Biol; 1995 Nov; 22(8):1049-52. PubMed ID: 8998465
[No Abstract] [Full Text] [Related]
6. Assessing intratumor distribution and uptake with MBBG versus MIBG imaging and targeting xenografted PC12-pheochromocytoma cell line.
Clerc J; Mardon K; Galons H; Loc'h C; Lumbroso J; Merlet P; Zhu J; Jeusset J; Syrota A; Fragu P
J Nucl Med; 1995 May; 36(5):859-66. PubMed ID: 7738664
[TBL] [Abstract][Full Text] [Related]
7. Novel [
Li X; Shi S; Zhou H; Zhao Z; Lu J
Mol Pharm; 2021 Oct; 18(10):3811-3819. PubMed ID: 34519204
[TBL] [Abstract][Full Text] [Related]
8. A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: pharmacological evaluation and PET experiments.
Helfenbein J; Loc'h C; Bottlaender M; Emond P; Coulon C; Ottaviani M; Fuseau C; Chalon S; Guenther I; Besnard JC; Frangin Y; Guilloteau D; Maziere B
Life Sci; 1999; 65(25):2715-26. PubMed ID: 10622281
[TBL] [Abstract][Full Text] [Related]
9. In vitro and animal validation of bromine-76-bromodeoxyuridine as a proliferation marker.
Bergström M; Lu L; Fasth KJ; Wu F; Bergström-Pettermann E; Tolmachev V; Hedberg E; Cheng A; Långström B
J Nucl Med; 1998 Jul; 39(7):1273-9. PubMed ID: 9669410
[TBL] [Abstract][Full Text] [Related]
10. Distribution and stability in the rat of a 76Br/125I-labelled polypeptide, epidermal growth factor.
Scott-Robson S; Capala J; Carlsson J; Malmborg P; Lundqvist H
Int J Rad Appl Instrum B; 1991; 18(2):241-6. PubMed ID: 2026501
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization and positron emission tomography evaluation of 4-[76Br]bromodexetimide and 4-[76Br]bromolevetimide for investigations of central muscarinic cholinergic receptors.
Loc'h C; Kassiou M; Strijckmans V; Bottlaender M; Katsifis A; Schmid L; Mazière M; Lambrecht RM; Mazière B
Nucl Med Biol; 1996 Apr; 23(3):235-43. PubMed ID: 8782231
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and experimental PET imaging of a bromine-76-labeled monoclonal anti-CEA antibody.
Lövqvist A; Sundin A; Ahlström H; Carlsson J; Lundqvist H
J Nucl Med; 1997 Mar; 38(3):395-401. PubMed ID: 9074527
[TBL] [Abstract][Full Text] [Related]
13. Preparation of [76Br]FLB 457 and [76Br]FLB 463 for examination of striatal and extrastriatal dopamine D-2 receptors with PET.
Loc'h C; Halldin C; Bottlaender M; Swahn CG; Moresco RM; Mazière M; Farde L; Mazière B
Nucl Med Biol; 1996 Aug; 23(6):813-9. PubMed ID: 8940725
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomographic investigations of central muscarinic cholinergic receptors with three isomers of [76Br]BrQNP.
Strijckmans V; Bottlaender M; Luo H; Ottaviani M; McPherson DW; Loc'h C; Fuseau C; Knapp FF; Mazière B
Eur J Nucl Med; 1997 May; 24(5):475-82. PubMed ID: 9142726
[TBL] [Abstract][Full Text] [Related]
15. 11C- and 76Br-labelled NNC 22-0010, selective dopamine D1 receptor radioligands for PET.
Foged C; Halldin C; Loc'h C; Mazière B; Karlsson P; Mazière M; Swahn CG; Farde L
Nucl Med Biol; 1996 Aug; 23(6):837-44. PubMed ID: 8940728
[TBL] [Abstract][Full Text] [Related]
16. Elimination of nonspecific radioactivity from [76Br]bromide in PET study with [76Br]bromodeoxyuridine.
Lu L; Bergström M; Fasth KJ; Wu F; Eriksson B; Långström B
Nucl Med Biol; 1999 Oct; 26(7):795-802. PubMed ID: 10628559
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of 76Br-labeled anti-CEA antibodies in pigs; aspects of dosimetry and PET imaging properties.
Lövqvist A; Lundqvist H; Lubberink M; Tolmachev V; Carlsson J; Sundin A
Med Phys; 1999 Feb; 26(2):249-58. PubMed ID: 10076983
[TBL] [Abstract][Full Text] [Related]
18. [A simple and rapid routine preparation of no-carrier added meta-I-123- and I-131-iodobenzylguanidine (I-123-MIBG and I-131-MIBG) for clinical nuclear medicine applications].
Samnick S; Kirsch CM
Nuklearmedizin; 1999; 38(7):292-6. PubMed ID: 10599069
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brain.
Sihver W; Fasth KJ; Horti AG; Koren AO; Bergström M; Lu L; Hagberg G; Lundqvist H; Dannals RF; London ED; Nordberg A; Långström B
J Neurochem; 1999 Sep; 73(3):1264-72. PubMed ID: 10461920
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of [76Br]bromofluorodeoxyuridine and its validation with regard to uptake, DNA incorporation, and excretion modulation in rats.
Lu L; Bergström M; Fasth KJ; Langström B
J Nucl Med; 2000 Oct; 41(10):1746-52. PubMed ID: 11038007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
